Positive feedback loop between NRAS^Q61R mutation and RAB27B expression in endothelial cells

Area of Science:

• Endothelial cell biology
• Molecular mechanisms of vascular anomalies
• Small GTPase function

Background:

• Somatic NRAS^Q61R mutations are implicated in vascular anomalies.
• RAB27B regulates NRAS palmitoylation and is crucial in leukemia.
• The role of RAB27B in NRAS^Q61R mutant endothelial cells remains unclear.

Purpose of the Study:

• To investigate the role of RAB27B in NRAS^Q61R-mutant endothelial cells.
• To elucidate the regulatory mechanisms of RAB27B expression in this context.
• To identify RAB27B as a potential therapeutic target for NRAS-mutant vascular anomalies.

Main Methods:

• Knockdown of RAB27B and RAB27A in human umbilical vein endothelial cells (HUVEC) overexpressing NRAS^Q61R.
• Assessment of cell proliferation, migration, and ERK activation.
• Analysis of RAB27B gene and protein expression levels.
• Treatment with MEK1/2 and PI3K/mTOR inhibitors.
• Identification of downstream transcription factors.

Main Results:

• RAB27B knockdown inhibited proliferation and migration of NRAS^Q61R-HUVEC by suppressing ERK activation.
• RAB27B expression was significantly elevated in NRAS^Q61R-HUVEC.
• MEK1/2 inhibition, but not PI3K/mTOR inhibition, decreased RAB27B gene expression.
• CCAAT enhancer binding protein beta was identified as a downstream transcription factor inducing RAB27B expression.

Conclusions:

• A positive feedback loop exists between NRAS^Q61R mutation and RAB27B expression in endothelial cells.
• RAB27B is associated with the dysfunction of NRAS^Q61R mutant endothelial cells.
• RAB27B represents a promising therapeutic target for NRAS-mutant vascular anomalies.